期刊
VACCINE
卷 32, 期 31, 页码 3883-3885出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2014.05.035
关键词
Human papillomavirus; Vaccination; Adolescence; Healthcare providers; Vaccine acceptability
资金
- Merck & Co, Inc. (IISP) [38094]
- National Cancer Institute [R25CA117865-05S1]
- Continuing Umbrella of Research Experience (CURE) Program
- Center for HPV Research by the Indiana University - Purdue University Indianapolis Signature Centers Initiative
Routine administration of the quadrivalent human papillomavirus (HPV) vaccine has been recommended for 11-12-year-old males since 2011, but coverage remains low. In a U.S. national sample of parents of 11-17-year-old males (n = 779), 78.6% of parents reported their sons had not received the HPV vaccine. The most common reason for non-vaccination (56.7%) was My doctor or healthcare provider has not recommended it. Parents citing only logistical reasons for non-vaccination (e.g., lack of recommendation, access, or education, n = 384) reported significantly higher vaccine acceptability than parents reporting a combination of attitudinal (e.g., concerns about vaccine safety or efficacy) and logistical barriers (n = 92), while parents citing only attitudinal barriers (n = 73) reported the lowest level of vaccine acceptability. In sum, many parents are willing but have not vaccinated sons due to logistical barriers, most commonly lack of healthcare provider recommendation. These findings have important implications for increasing HPV vaccination coverage among adolescent males. (C) 2014 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据